Insider Transactions Reported by 13 Insiders of FENNEC PHARMACEUTICALS INC.

Symbol
FENC on Nasdaq
Location
Research Triangle Park, NC

Insiders trading volume in the past year

FENNEC PHARMACEUTICALS INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Southpoint Capital Advisors LP 10%+ Owner $20,585,557 -$10,341,902 -33% 24 Dec 2025
Rosty Raykov Director $4,691,501 -$1,043,382 -18% 02 Feb 2026
Robert Andrade Chief Financial Officer $3,638,055 31 Jan 2026
Chris Rallis Director $2,107,609 -$33,122 -1.5% 10 Oct 2025
Khalid Islam Director $1,773,000 03 Jun 2025
Marco Brughera Director $1,698,494 03 Jun 2025
Jeffrey S. Hackman Chief Executive Officer, Director $1,517,100 +$104,602 +7.4% 16 May 2025
Jodi Cook Director $1,103,200 03 Jun 2025
Adrian Haigh Chief Operating Officer $832,168 16 May 2024
Christiana Cioffi Chief Strategy Officer $634,500 28 Mar 2025
Pierre Sayad Chief Medical Officer $634,500 28 Mar 2025
Terry Evans Chief Commercial Officer $634,500 28 Mar 2025
Shubh Goel Chief Commercial Officer 20 Dec 2021

Recent Insider Transactions by Companies or Individuals for FENNEC PHARMACEUTICALS INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.